Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Texas was posted on January 15, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Individual Investigator Research Awards for Clinical Trials

Closed
542-AR_FY26_IIRACTState & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is soliciting quotes for a one-time purchase of antibiotics to be stockpiled for post-exposure response to Category A agents, including anthrax, plague, and tularemia. The requirement consists of 30,000 tablets of Ciprofloxacin Hydrochloride (500mg/dose) and 200,000 tablets of Doxycycline Monohydrate (100mg/dose). All products must be FDA approved and comply with CDC and California Department of Public Health standards. Strict adherence to cold-chain storage and temperature-controlled guidelines is required, with the use of temperature-monitoring devices during transit and full lot-level traceability from production to delivery. The contract must be completed within the city's fiscal year ending June 30, 2027, with a required delivery lead time of four business days from the date of order to the delivery location at 1845 N Fair Oaks Ave, Pasadena, CA. Bidders must submit pricing electronically via the city's eProcurement Portal, ensuring that quoted unit prices include all delivery costs and sales tax, as no separate freight or handling fees will be accepted. The response deadline is November 4, 2026. Compliance requirements include the submission of a Unique Entity Identifier (UEI), IRS Form W-9, and various vendor questionnaires regarding equal opportunity and legal status. The procurement is subject to federal regulations, including FEMA terms and conditions, the Davis-Bacon Act for prevailing wages, and the Byrd Anti-Lobbying Amendment. Award will be based on the ability to deliver the specified antibiotics at a competitive price while meeting all regulatory, insurance, and technical specifications.
Public Health Department

POSTED

about 24 hours ago

DEADLINE

in 6 days
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-27-T-0183
This solicitation, identified as SPE2DP-27-T-0183, is a Request for Quotations for the procurement of sunscreen preparation under NSN 6505-01-657-9247. The required product is an over-the-counter topical sunscreen with an SPF of 50, containing 4.5% titanium dioxide and 4% zinc oxide. It must be sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, and biodegradable. The unit of issue is a package of 24 three-ounce tubes. The product has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements are specified between 15 and 30 degrees Celsius in a cool, dry place. The contract specifies a delivery timeframe of five days with an original required delivery date of July 21, 2026. Delivery is FOB Destination, with shipments directed to locations including Fort Bragg, North Carolina, and North Stonington, Connecticut. Packaging must adhere to ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, with palletization following RP001. Marking must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment requests. The procurement is subject to various federal regulations, including the Buy American Act and DFARS cybersecurity reporting standards. Quotes must be submitted via the DLA Internet Bid Board System. The solicitation is managed by the Medical Supply Chain Pharma FSA under the Department of Defense, with a primary point of contact at DLA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 4 days

AI Contract Overview

Show more

This contract supports applications proposing innovative, hypothesis-driven cancer clinical studies involving adult or pediatric patients enrolled prospectively in clinical trials. The focus is on research exploring new or repurposed drugs, hormonal therapies, immune therapies, surgical interventions, radiation treatments, stem cell transplants, combination therapies, or therapeutic devices. The clinical trials must be planned to commence immediately upon contract award, emphasizing the need for readiness and timely initiation. The funding range for this program is between one million and five million dollars, with the goal of advancing impactful cancer treatment research within Texas. The solicitation, titled "Individual Investigator Research Awards for Clinical Trials," is posted by Texas Grants and is open until May 6, 2025. It is targeted at organizations classified under the State, Local, Education, and Nonprofit (SLED) sector, with the primary contact being Myriam Casillas. The program aims to foster innovative clinical research that can lead to improved therapeutic options for cancer patients, with a clear emphasis on projects that are ready to begin immediately after funding is awarded. Interested applicants can find more details and submit proposals through the provided online link.

General Info

Place of Performance

TX, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyTexas Grants
Contacts1 person available
OfficeN/A
Organization / AgencyTexas Grants
Office AddressN/A
Contacts
Myriam Casillas

Full Description

Show more
Supports applications that propose innovative cancer clinical studies in adults or children and adolescents that are hypothesis driven and involve patients enrolled prospectively on a clinical trial. Areas of interest include clinical studies of new or repurposed drugs, hormonal therapies, immune therapies, surgery, radiation therapy, stem cell transplantation, combinations of interventions, or therapeutic devices. Clinical trial must be planned to begin when contract is awarded.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS